These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23054707)

  • 1. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
    Bae JS
    Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1, a potent proinflammatory cytokine in sepsis.
    Huang W; Tang Y; Li L
    Cytokine; 2010 Aug; 51(2):119-26. PubMed ID: 20347329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytokine activity of HMGB1.
    Yang H; Wang H; Czura CJ; Tracey KJ
    J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
    Erlandsson Harris H; Andersson U
    Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury.
    Xu W; Lu Y; Yao J; Li Z; Chen Z; Wang G; Jing H; Zhang X; Li M; Peng J; Tian X
    Shock; 2014 Nov; 42(5):440-7. PubMed ID: 25004063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin-6-O-β-D-glucoside inhibits HMGB1-induced inflammatory responses in vitro and in vivo.
    Lee W; Ku SK; Kim TH; Bae JS
    Food Chem Toxicol; 2013 Feb; 52():97-104. PubMed ID: 23146691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
    Musumeci D; Roviello GN; Montesarchio D
    Pharmacol Ther; 2014 Mar; 141(3):347-57. PubMed ID: 24220159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 as a DNA-binding cytokine.
    Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
    J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
    Lutz W; Stetkiewicz J
    Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
    Czura CJ; Yang H; Tracey KJ
    J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in high mobility group box-1 protein mediated multiple organ dysfunction and its potential interventional strategies].
    Yao YM; Xu S; Sheng ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):459-65. PubMed ID: 19209785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-mobility group box-1 isoforms as potential therapeutic targets in sepsis.
    Parrish W; Ulloa L
    Methods Mol Biol; 2007; 361():145-62. PubMed ID: 17172710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
    Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
    Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of HMGB1-targeting agents in sepsis.
    Wang H; Zhu S; Zhou R; Li W; Sama AE
    Expert Rev Mol Med; 2008 Nov; 10():e32. PubMed ID: 18980707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial infection induces the secretion of high-mobility group box 1 protein.
    Grover A; Taylor J; Troudt J; Keyser A; Sommersted K; Schenkel A; Izzo AA
    Cell Microbiol; 2008 Jun; 10(6):1390-404. PubMed ID: 18331466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytokine activity of HMGB1--extracellular escape of the nuclear protein.
    Sun NK; Chao CC
    Chang Gung Med J; 2005 Oct; 28(10):673-82. PubMed ID: 16382751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 in sepsis.
    Andersson U; Tracey KJ
    Scand J Infect Dis; 2003; 35(9):577-84. PubMed ID: 14620138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high mobility group box-1 protein in severe sepsis.
    Sunden-Cullberg J; Norrby-Teglund A; Treutiger CJ
    Curr Opin Infect Dis; 2006 Jun; 19(3):231-6. PubMed ID: 16645483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.